Vcanbio Cell & Gene Engineering Corp Ltd Cash Flow Reinvestment Rate
Vcanbio Cell & Gene Engineering Corp Ltd cash flow reinvestment rate. Vcanbio Cell & Gene Engineering Corp Ltd (600645) has a Cash Flow Reinvestment Rate of 0.13x as of September 2025, reinvesting CN¥13.28 Million (capex CN¥13.28 Million ) from operating cash flow of CN¥103.70 Million. Explore Vcanbio Cell & Gene Engineering Corp Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Vcanbio Cell & Gene Engineering Corp Ltd (1999–2025)
Cash flow reinvestment rate of Vcanbio Cell & Gene Engineering Corp Ltd from 1999 to 2025. Historical reinvestment intensity for Vcanbio Cell & Gene Engineering Corp Ltd across 25 annual periods. Explore Vcanbio Cell & Gene Engineering Corp Ltd (600645) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Vcanbio Cell & Gene Engineering Corp Ltd Cash Flow Reinvestment Rate by Year (1999–2025)
Vcanbio Cell & Gene Engineering Corp Ltd cash flow reinvestment rate by year from 1999 to 2025. Year-by-year capital reinvestment analysis for Vcanbio Cell & Gene Engineering Corp Ltd. For the full cash flow conversion analysis, see Vcanbio Cell & Gene Engineering Corp Ltd cash conversion from operations.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.39x | CN¥748.16 Million | CN¥313.63 Million | CN¥49.56 Million | ▲ +872.0% |
| 2024 | 0.25x | CN¥69.99 Million | CN¥285.19 Million | CN¥67.32 Million | ▼ -59.0% |
| 2023 | 0.60x | CN¥179.11 Million | CN¥299.02 Million | CN¥88.61 Million | ▼ -20.6% |
| 2022 | 0.75x | CN¥197.53 Million | CN¥261.89 Million | CN¥99.19 Million | ▲ +65.0% |
| 2021 | 0.46x | CN¥146.69 Million | CN¥320.96 Million | CN¥127.74 Million | ▼ -76.3% |
| 2020 | 1.93x | CN¥471.61 Million | CN¥244.35 Million | CN¥91.72 Million | ▼ -17.5% |
| 2019 | 2.34x | CN¥564.98 Million | CN¥241.49 Million | CN¥122.95 Million | ▲ +80.1% |
| 2018 | 1.30x | CN¥168.98 Million | CN¥130.08 Million | CN¥128.13 Million | ▼ -48.4% |
| 2017 | 2.52x | CN¥176.96 Million | CN¥70.27 Million | CN¥83.02 Million | ▼ -32.9% |
| 2016 | 3.75x | CN¥538.92 Million | CN¥143.67 Million | CN¥269.85 Million | ▼ -90.8% |
| 2015 | 40.66x | CN¥332.43 Million | CN¥8.17 Million | CN¥128.70 Million | ▲ +14791.4% |
| 2014 | 0.27x | CN¥60.47 Million | CN¥221.45 Million | CN¥60.47 Million | ▼ -57.1% |
| 2013 | 0.64x | CN¥70.43 Million | CN¥110.72 Million | CN¥70.43 Million | ▼ -19.4% |
| 2012 | 0.79x | CN¥55.56 Million | CN¥70.41 Million | CN¥55.56 Million | ▲ +488.4% |
| 2011 | 0.13x | CN¥14.81 Million | CN¥110.44 Million | CN¥14.81 Million | ▲ +352.1% |
| 2010 | 0.03x | CN¥5.22 Million | CN¥175.93 Million | CN¥5.22 Million | ▼ -78.6% |
| 2009 | 0.14x | CN¥17.32 Million | CN¥124.92 Million | CN¥17.32 Million | ▼ -17.0% |
| 2008 | 0.17x | CN¥20.32 Million | CN¥121.60 Million | CN¥20.32 Million | ▲ +4.1% |
| 2007 | 0.16x | CN¥17.92 Million | CN¥111.68 Million | CN¥17.92 Million | ▼ -74.4% |
| 2006 | 0.63x | CN¥47.67 Million | CN¥76.12 Million | CN¥47.67 Million | ▼ -7.8% |
| 2005 | 0.68x | CN¥57.55 Million | CN¥84.69 Million | CN¥57.55 Million | ▲ +44.2% |
| 2004 | 0.47x | CN¥27.23 Million | CN¥57.76 Million | CN¥27.23 Million | ▼ -45.5% |
| 2003 | 0.86x | CN¥36.08 Million | CN¥41.74 Million | CN¥36.08 Million | ▲ +219.3% |
| 2000 | 0.27x | CN¥8.58 Million | CN¥31.71 Million | CN¥8.58 Million | ▼ -87.2% |
| 1999 | 2.12x | CN¥8.76 Million | CN¥4.13 Million | CN¥8.76 Million | — |